|
Mar 4, 2026 |
Warren Eric
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
60.0
|
+6,200
|
0.33%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Congleton Jon
|
CEO |
Neutral |
90.0
|
+140,900
|
22.04%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
SBLENDORIO GLENN
|
Director |
Neutral |
90.0
|
+6,200
|
100.00%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Gold Alexander M
|
Director |
Neutral |
90.0
|
+6,200
|
100.00%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Karydas Daphne
|
Director |
Neutral |
90.0
|
+6,200
|
100.00%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Slingsby Brian Taylor
|
Director |
Neutral |
55.0
|
+6,200
|
0.08%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
AKKARAJU SRINIVAS
|
Director |
Neutral |
55.0
|
+6,200
|
0.11%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
DiRocco Derek
|
Director |
Neutral |
90.0
|
+6,200
|
100.00%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
90.0
|
+38,400
|
87.10%
|
✗
|
- |
| Feb 19, 2026 |
Feb 20, 2026 |
Levy Adam Scott
|
CFO |
Neutral |
90.0
|
+39,900
|
461.91%
|
✗
|
- |
| Feb 17, 2026 |
Feb 17, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
50.6
|
-417
|
-0.94%
|
✓
|
$11.5K |
| Feb 12, 2026 |
Feb 13, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
28.8
|
-20,404
|
-7.65%
|
✓
|
$569.8K |
| Feb 9, 2026 |
Feb 11, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
38.8
|
-2,171
|
-4.13%
|
✓
|
$65.6K |
| Jan 20, 2026 |
Jan 20, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
50.6
|
-416
|
-0.82%
|
✓
|
$13.4K |
| Jan 13, 2026 |
Jan 15, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
10.0
|
-19,076
|
-27.44%
|
✓
|
$623.1K |
| Jan 12, 2026 |
Jan 13, 2026 |
Congleton Jon
|
CEO |
Sell |
41.3
|
-16,236
|
-2.48%
|
✓
|
$529.6K |
| Jan 12, 2026 |
Jan 13, 2026 |
Levy Adam Scott
|
CFO |
Sell |
10.0
|
-10,758
|
-55.47%
|
✓
|
$345.7K |
| Jan 9, 2026 |
Jan 13, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
32.5
|
-8,518
|
-6.45%
|
✓
|
$277.3K |
| Jan 2, 2026 |
Jan 6, 2026 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
8.1
|
-262,752
|
-51.62%
|
✓
|
$9.3M |
| Nov 21, 2025 |
Nov 24, 2025 |
Congleton Jon
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 20, 2025 |
Nov 21, 2025 |
Slingsby Brian Taylor
|
Director |
Sell |
15.0
|
-1,000,000
|
-11.23%
|
✗
|
$43.4M |
| Nov 11, 2025 |
Nov 13, 2025 |
Levy Adam Scott
|
CFO |
Sell |
16.3
|
-119,524
|
-86.04%
|
✗
|
$5.4M |
| Nov 11, 2025 |
Nov 13, 2025 |
Congleton Jon
|
CEO |
Sell |
16.3
|
-200,000
|
-24.06%
|
✗
|
$9.1M |
| Nov 13, 2025 |
Nov 13, 2025 |
Karydas Daphne
|
Director |
Sell |
20.0
|
-15,000
|
-100.00%
|
✗
|
$689.8K |
| Nov 11, 2025 |
Nov 13, 2025 |
Gold Alexander M
|
Director |
Sell |
17.5
|
-34,675
|
-83.34%
|
✗
|
$1.6M |
| Oct 13, 2025 |
Oct 15, 2025 |
Levy Adam Scott
|
CFO |
Sell |
26.3
|
-10,758
|
-8.43%
|
✓
|
$452K |
| Oct 13, 2025 |
Oct 15, 2025 |
Congleton Jon
|
CEO |
Sell |
42.5
|
-15,100
|
-1.78%
|
✓
|
$644.3K |
| Oct 15, 2025 |
Oct 15, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
22.5
|
-10,369
|
-12.72%
|
✓
|
$446K |
| Sep 15, 2025 |
Sep 16, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
22.5
|
-11,367
|
-12.24%
|
✓
|
$409.3K |
| Sep 4, 2025 |
Sep 8, 2025 |
AKKARAJU SRINIVAS
|
Director |
Buy |
100.0
|
+588,235
|
10.37%
|
✗
|
$15M |
| Sep 4, 2025 |
Sep 8, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+1,176,470
|
27.49%
|
✗
|
$30M |
| Aug 12, 2025 |
Aug 14, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
25.0
|
-11,365
|
-10.90%
|
✓
|
$147K |
| Jul 28, 2025 |
Jul 30, 2025 |
Levy Adam Scott
|
CFO |
Sell |
17.5
|
-73,678
|
-35.66%
|
✗
|
$1.1M |
| Jul 11, 2025 |
Jul 15, 2025 |
Congleton Jon
|
CEO |
Sell |
45.0
|
-15,884
|
-1.84%
|
✓
|
$230.4K |
| Jul 11, 2025 |
Jul 15, 2025 |
Levy Adam Scott
|
CFO |
Sell |
37.5
|
-10,758
|
-4.95%
|
✓
|
$155.5K |
| Jul 14, 2025 |
Jul 15, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
25.0
|
-11,366
|
-10.40%
|
✓
|
$165.9K |
| Jun 12, 2025 |
Jun 16, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
25.0
|
-11,366
|
-10.06%
|
✓
|
$165.9K |
| May 14, 2025 |
May 15, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
28.8
|
-11,366
|
-9.63%
|
✓
|
$173.8K |
| May 12, 2025 |
May 13, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
58.8
|
-
|
0.00%
|
✓
|
- |
| Mar 13, 2025 |
Apr 25, 2025 |
Slingsby Brian Taylor
|
Director |
Buy |
92.5
|
+259,259
|
3.00%
|
✗
|
$3.5M |
| Apr 14, 2025 |
Apr 15, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
28.8
|
-11,366
|
-9.24%
|
✓
|
$165.2K |
| Apr 11, 2025 |
Apr 15, 2025 |
Levy Adam Scott
|
CFO |
Sell |
37.5
|
-10,757
|
-4.76%
|
✓
|
$129.7K |
| Apr 11, 2025 |
Apr 15, 2025 |
Congleton Jon
|
CEO |
Sell |
45.0
|
-15,319
|
-1.75%
|
✓
|
$186.8K |
| Apr 1, 2025 |
Apr 3, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
7.5
|
-55,771
|
-32.34%
|
✓
|
$879K |
| Mar 13, 2025 |
Mar 17, 2025 |
Samsara BioCapital GP, LLC
|
10% Owner |
Buy |
100.0
|
+600,000
|
11.82%
|
✗
|
$8.1M |
| Mar 13, 2025 |
Mar 17, 2025 |
AKKARAJU SRINIVAS
|
Director |
Buy |
100.0
|
+600,000
|
11.82%
|
✗
|
$8.1M |
| Mar 13, 2025 |
Mar 17, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+1,296,296
|
43.45%
|
✗
|
$17.5M |
| Mar 12, 2025 |
Mar 13, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
Levy Adam Scott
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
AKKARAJU SRINIVAS
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
Slingsby Brian Taylor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
DiRocco Derek
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
Gold Alexander M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
Congleton Jon
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
Karydas Daphne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 24, 2025 |
SBLENDORIO GLENN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 13, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 13, 2025 |
Jan 15, 2025 |
Levy Adam Scott
|
CFO |
Sell |
37.5
|
-10,757
|
-4.54%
|
✓
|
$97.9K |
| Jan 13, 2025 |
Jan 15, 2025 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 13, 2025 |
Jan 15, 2025 |
Congleton Jon
|
CEO |
Sell |
41.3
|
-18,333
|
-2.05%
|
✓
|
$166.1K |
| May 22, 2024 |
Jan 7, 2025 |
Slingsby Brian Taylor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2024 |
Dec 13, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 11, 2024 |
Nov 12, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
37.5
|
-5,026
|
-3.44%
|
✓
|
$75.4K |
| Nov 6, 2024 |
Nov 8, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
17.5
|
-25,482
|
-15.78%
|
✓
|
$383.1K |
| Oct 11, 2024 |
Oct 15, 2024 |
Levy Adam Scott
|
CFO |
Sell |
37.5
|
-10,757
|
-4.34%
|
✓
|
$146K |
| Oct 11, 2024 |
Oct 15, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 11, 2024 |
Oct 15, 2024 |
Congleton Jon
|
CEO |
Sell |
45.0
|
-15,271
|
-1.68%
|
✓
|
$206.4K |
| Sep 11, 2024 |
Sep 12, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 12, 2024 |
Aug 13, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2024 |
Jul 26, 2024 |
Slingsby Brian Taylor
|
Director |
Sell |
16.3
|
-550,000
|
-5.98%
|
✗
|
$7.2M |
| Jul 16, 2024 |
Jul 18, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
52.5
|
-525
|
-0.51%
|
✓
|
$7.9K |
| Jul 11, 2024 |
Jul 12, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 12, 2024 |
Levy Adam Scott
|
CFO |
Sell |
37.5
|
-10,757
|
-4.16%
|
✓
|
$141.4K |
| Jul 11, 2024 |
Jul 12, 2024 |
Congleton Jon
|
CEO |
Sell |
45.0
|
-15,746
|
-1.70%
|
✓
|
$210.1K |
| Jun 17, 2024 |
Jun 20, 2024 |
Congleton Jon
|
CEO |
Sell |
30.0
|
-49,313
|
-5.05%
|
✓
|
$592K |
| Jun 13, 2024 |
Jun 17, 2024 |
Gold Alexander M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 17, 2024 |
Gold Alexander M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Congleton Jon
|
CEO |
Sell |
30.0
|
-72,797
|
-6.94%
|
✓
|
$924.2K |
| Jun 11, 2024 |
Jun 13, 2024 |
Levy Adam Scott
|
CFO |
Sell |
5.0
|
-96,815
|
-27.48%
|
✓
|
$1.3M |
| Jun 11, 2024 |
Jun 13, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 28, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 23, 2024 |
DiRocco Derek
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 23, 2024 |
SBLENDORIO GLENN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 23, 2024 |
AKKARAJU SRINIVAS
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 23, 2024 |
Karydas Daphne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 23, 2024 |
Slingsby Brian Taylor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 23, 2024 |
Litzka Olivier
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2024 |
May 15, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 10, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Sell |
55.0
|
-100
|
-0.15%
|
✓
|
$1.5K |
| Apr 11, 2024 |
Apr 15, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2024 |
Mar 13, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2024 |
Feb 15, 2024 |
Rodman David Malcom
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2024 |
Feb 15, 2024 |
Levy Adam Scott
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2024 |
Feb 15, 2024 |
Congleton Jon
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
AKKARAJU SRINIVAS
|
Director |
Neutral |
90.0
|
+555,555
|
12.29%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Samsara BioCapital GP, LLC
|
10% Owner |
Buy |
100.0
|
+555,555
|
12.29%
|
✗
|
$7.5M |
| Feb 12, 2024 |
Feb 14, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
90.0
|
+1,672,508
|
52.62%
|
✗
|
- |